<?xml version="1.0" encoding="UTF-8"?>
<p>A composition containing yeast dsRNA (the active ingredient of the drug Ridostin) and the polymer polyvinylpyrrolidone exhibited prolonged activating effect on the system of nonspecific resistance and reduced toxicity than the initial drug [
 <xref ref-type="bibr" rid="CR81">81</xref>].
</p>
